advancing innovation to save lives

GHTC director pens AJTMH editorial discussing the importance of the Fogarty Center

Jamie Bay Nishi, director of GHTC, penned an editorial for the American Journal of Tropical Medicine and Hygiene, discussing the importance of the Fogarty International Center at the US National Institutes of Health, calling the center an "unsung hero for global health research and development."
Learn More

Return on innovation

A new report from GHTC examines the impact of US government investment in global health R&D at home and abroad, from delivering lifesaving tools for the world’s most vulnerable people to generating economic and security returns for the United States.
Learn More


PATH recently launched Digital Square—new initiative, comprised of 40+ partner organizations, encourages more efficient investment in digital health technology solutions in low- and middle-income countries through an innovative co-investment model.
Learn More

GHTC works to save and improve lives by encouraging the research and development of essential health technologies. We are a coalition of more than 25 nonprofit organizations advancing policies to accelerate the creation of new drugs, vaccines, diagnostics, and other health tools that bring healthy lives within reach for all people.

Why we're needed

Health technologies have the potential to save millions of lives. New tools are needed to slow the global threat of diseases, including HIV/AIDS, malaria, tuberculosis, and neglected tropical diseases, and tackle many other pressing health needs. For diseases and conditions primarily affecting people in the world’s poorest places, there is little to no commercial market to spur R&D. Strong investment and innovative solutions are needed to catalyze the development of new technologies to bring health and opportunity in reach for all people.

Learn more
PATH/Matthew Dakin
GHTC director quoted in Devex article on new AMR innovation hub

Jamie Bay Nishi, director of GHTC, was quoted in a Devex article focused on the new antimicrobial innovation hub in Germany.

Learn More
PATH/Aaron Joel Santos
Brink News republishes GE Reports article by GHTC director

Brink News picked up GE Report's article by GHTC Director Jamie Bay Nishi. The article highlights findings from the coalition's report Return on innovation: Why global health R&D is a smart investment for the United States.

View All News & Events

Community Event

PATH/Patrick McKern
Exploring Partnership Governance in Global Health: A Workshop
National Academies of Sciences, Engineering, and Medicine
Learn More

Member Event

ASTMH 66th Annual Meeting
Learn More
View All Events
PATH/Evelyn Hockstein
GHTC Photo Reception Highlights Research Breakthroughs in Kenya

In countries like Kenya, some of the most incredible global health research is taking place to develop new drugs, vaccines, diagnostics and other health products. In addition, previous research has lead to the roll-out of lifesaving health tools such as HIV/AIDS drugs, vaccines to protect children from pneumonia, and insecticide-treated bednets to prevent malaria.

Read More
New report shows a decline in funding for neglected disease R&D

Earlier today, the fourth annual G-FINDER report was released. This resource, developed by Policy Cures, is the only one of its kind that maps the global level of investment in developing new vaccines, drugs, diagnostics, and other tools that address 31 neglected diseases. This year’s report studies funding levels and trends in 2010.

Read More
View Breakthroughs Blog

Our members work to improve health worldwide